By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Lpath, Inc. 

4025 Sorrento Valley Boulevard

San Diego  California  92121  U.S.A.
Phone: 858-678-0800 Fax: 858-678-0900



Drug Discovery

Company News
Lpath (LPTN) Reports Favorable Results From Phase 1 Study Of Lpathomab 4/19/2016 6:35:53 AM
Lpath (LPTN) Completes Dosing In The Lpathomab Phase 1 Safety Study 2/1/2016 6:24:08 AM
Lpath (LPTN) To Hold Corporate Update Conference Call And Live Webcast On Tuesday, November 17th 11/16/2015 10:22:27 AM
Lpath (LPTN)To Present Nexus Phase 2 Study Data In Wet Age-Related Macular Degeneration At The 2015 American Academy of Ophthalmology Annual Meeting Retinal Subspecialty Day 11/5/2015 6:18:52 AM
Lpath (LPTN) Appoints Gary Atkinson Interim CEO 9/30/2015 6:12:07 AM
Lpath (LPTN) Initiates First-In-Human Dosing In Phase 1 Clinical Trial Of Lpathomab 9/15/2015 6:16:09 AM
Lpath (LPTN) Announces Plan To Begin Lpathomab Clinical Trial 7/23/2015 8:51:39 AM
Lpath (LPTN) Shares Fall 80%, Will Cut Jobs After Second Drug Flunks Phase II Trial 5/20/2015 6:37:38 AM
Lpath, Inc. (LPTN) Reports Results For ASONEP Phase 2a Study In Renal Cell Carcinoma 3/25/2015 6:20:43 AM
Lpath, Inc. (LPTN) To Hold Investor Update Conference Call 3/23/2015 9:15:32 AM